These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 971792)

  • 1. Leukocyte chemotaxis in diabetic patients and their nondiabetic first-degree relatives.
    Molenaar DM; Palumbo PJ; Wilson WR; Ritts RE
    Diabetes; 1976; 25(2 SUPPL):880-3. PubMed ID: 971792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband.
    Tripathy D; Lindholm E; Isomaa B; Saloranta C; Tuomi T; Groop L
    Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1297-303. PubMed ID: 12954593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin antibodies in diabetics receiving a single type of insulin.
    Mincu I; Cheţa D
    Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study on the types of diabetes mellitus in first degree relatives of diabetic patients.
    Cheţa D; Dumitrescu C; Georgescu M; Cocioabă G; Lichiardopol R; Stamoran M; Ionescu-Tîrgovişte C; Păunescu-Georgescu M; Mincu I
    Diabete Metab; 1990; 16(1):11-5. PubMed ID: 2332093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperinsulinemia and insulin resistance in nondiabetic first-degree relatives of patients in familial NIDDM pedigrees].
    Zhang S; Li C; Yu L
    Zhonghua Yi Xue Za Zhi; 1998 Aug; 78(8):585-7. PubMed ID: 11038806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The risk of diabetes mellitus in relatives of diabetics treated with insulin].
    Barros H; Pignatelli D; Pereira S; Oliveira JP; Maia JC
    Acta Med Port; 1994 Jun; 7(6):349-52. PubMed ID: 7942136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
    Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial pressure in clinically apparent diabetics.
    Keen H; Track NS; Sowry GS
    Diabete Metab; 1975 Sep; 1(3):159-78. PubMed ID: 1234579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of islet cell antibodies and its correlation with glucose and insulin response to oral glucose tolerance test in 1st degree relatives of insulin dependent diabetes mellitus probands.
    Merchant PC; Godse CS; Varthakavi PK; Patel KL; Nihalani KD
    J Assoc Physicians India; 1998 May; 46(5):417-23. PubMed ID: 11273280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes.
    Cnop M; Vidal J; Hull RL; Utzschneider KM; Carr DB; Schraw T; Scherer PE; Boyko EJ; Fujimoto WY; Kahn SE
    Diabetes Care; 2007 Mar; 30(3):677-82. PubMed ID: 17327340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heritability of diabetes mellitus in Ethiopian diabetics.
    Mengesha B; Abdulkadir J
    East Afr Med J; 1997 Jan; 74(1):37-40. PubMed ID: 9145576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin antibodies and the control of diabetes.
    Dixon K; Exon PD; Malins JM
    Q J Med; 1975 Oct; 44(176):543-53. PubMed ID: 1105646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prediction of type 1 diabetes mellitus in first degree Czech relatives of diabetic patients].
    Vavrinec J; Cinek O; Sumník Z; Kolousková S; Malcová H; Drevínek P; Snajderová M
    Vnitr Lek; 2002 Jun; 48(6):483-9. PubMed ID: 12132348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behaviour of insulin antibodies in diabetics treated with different insulins.
    Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E
    Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The influence of metabolic control on chemotactic activity in insulin-dependent diabetes mellitus (author's transl)].
    Endler AT; Zielinski C; Schernthaner G; Ludwig H
    Wien Klin Wochenschr; 1978 Oct; 90(20):747-51. PubMed ID: 716430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
    Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
    Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in daily insulin requirement in diabetics switched to monocomponent insulin treatment].
    Bruni B; Turco GL
    Minerva Med; 1973 Nov; 64(80):4224-31. PubMed ID: 4765430
    [No Abstract]   [Full Text] [Related]  

  • 19. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
    Anderson OO
    Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics, obesity, and environmental risk factors associated with type 2 diabetes.
    Bener A; Zirie M; Al-Rikabi A
    Croat Med J; 2005 Apr; 46(2):302-7. PubMed ID: 15849854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.